Inland Norway University of Applied Sciences
Lillehammer, Norway
NCT Number: NCT04196725
Participants with lymphedema secondary to cancer treatment will participate in a two week rehabilitation programme focusing on physical therapy treatment and a two week programme focusing on physical exercise. The purpose is to assess the effect of the rehabilitation programmes on lymphedema and measures of physical performance.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Lillehammer, Norway
Traditionally, physical therapy treatment, e.g. manual lymphatic drainage and compression bandaging is used for treatment of cancer treatment induced lymphedema. Alternatively, lifestyle interventions are used as treatment, with focus on physical exercise. However, the effects of such interventions are scarcely documented. Thus, the purpose of this study is to assess the effect of physical therapy treatment and physical exercise on lymphedema and measures of physical performance.
The study will be performed in a randomized cross-over design, encompassing 26 participants with secondary lymphedema related to cancer treatment. Firstly, half of the participants in the intervention group will be randomized to a two week rehabilitation programme focusing on physical activity while the other half to a rehabilitation programme focusing on physical therapy treatment, and the other way around three months later. In addition. there will be a control group with cancer related lymphedema not participating in any rehabilitation programme. Pre and post of each of the two week rehabilitation periods the following measurements will be performed: The magnitude of lymphedema by volume measurements of the limbs (by DXA); measurements of maximal strength, range of movement, flexibility, balance, physical functionality and questionnaires about perceived health and level of physical activity.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-
Two weeks rehabilitation programme focusing on physical therapy treatment, e.g. manual lymphatic drainage and compression bandaging
Two weeks rehabilitation programme focusing on physical activity
Time frame: Change from before to the end of each of the two week rehabilitation programmes.
Ratio of the volume of affected limb vs volume of nonaffected limb measured by DXA
Time frame: Measured immediately before and at the end of each of the two week rehabilitation programmes.
In handgrip and knee-extension
Time frame: Measured immediately before and at the end of each of the two week rehabilitation programmes.
One leg balance test
Time frame: Measured immediately before and at the end of each of the two week rehabilitation programmes.
Sit and reach test
Time frame: Measured immediately before and at the end of each of the two week rehabilitation programmes.
Back scratch test
Time frame: Measured immediately before and at the end of each of the two week rehabilitation programmes.
Stand up and walk test
Time frame: Measured immediately before and at the end of each of the two week rehabilitation programmes.
Range of joint movement in the knee
Time frame: Measured immediately before and at the end of each of the two week rehabilitation programmes.
Range of joint movement in the elbow
Time frame: Measured immediately before and at the end of each of the two week rehabilitation programmes.
Perceived health assessed by questionnaire
Time frame: Questionnaire will be completed immediately before the rehabilitation programmes, assessing the level of physical activity the prior three months.
Level of physical activity assessed by questionnaire
Inland Norway University of Applied Sciences
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04797390
Hemic and Lymphatic Diseases, Lymphatic Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT04934098
Breast Cancer Lymphedema, Breast Cancer Related Lymphedema
Rio de Janeiro, Brazil
View Trial DetailsNCT06606145
Hemic and Lymphatic Diseases, Lymphatic Diseases
Jette, Brussel Capital, Belgium
View Trial DetailsNCT04881604
Breast Cancer Lymphedema, Breast Cancer Related Lymphedema
Rio de Janeiro, Brazil
View Trial Details